NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
49,997,195
Share change
+803,412
Total reported value
$79,546,612
Put/Call ratio
7201%
Price per share
$1.59
Number of holders
79
Value change
+$1,020,513
Number of buys
26
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q1 2015

As of 31 Mar 2015, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,997,195 shares. The largest 10 holders included Platinum Management (NY) LLC, Commerzbank Aktiengesellschaft /FI, SUSQUEHANNA INTERNATIONAL GROUP, LLP, VANGUARD GROUP INC, BlackRock Fund Advisors, GOLDMAN SACHS GROUP INC, STATE STREET CORP, UBS Group AG, BlackRock Institutional Trust Company, N.A., and NORTHERN TRUST CORP. This page lists 79 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.